Table 3.
N = 571 patients | Any TEAEa n (%) | Lacosamide‐related TEAE n (%) |
---|---|---|
Any | 277 (48.5) | 164 (28.7) |
Fatigue | 71 (12.4) | 59 (10.3) |
Dizziness | 63 (11.0) | 50 (8.8) |
Convulsion | 29 (5.1) | 10 (1.8) |
Headache | 24 (4.2) | 15 (2.6) |
Nausea | 21 (3.7) | 17 (3.0) |
Depression | 17 (3.0) | 7 (1.2) |
Tremor | 15 (2.6) | 9 (1.6) |
Gait disturbance | 14 (2.5) | 11 (1.9) |
Somnolence | 12 (2.1) | 11 (1.9) |
TEAE, treatment‐emergent adverse event.
In ≥2% of patients.